These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18540837)

  • 1. Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs.
    Maher S; Brayden DJ; Feighery L; McClean S
    Crit Rev Ther Drug Carrier Syst; 2008; 25(2):117-68. PubMed ID: 18540837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
    Salamat-Miller N; Johnston TP
    Int J Pharm; 2005 Apr; 294(1-2):201-16. PubMed ID: 15814245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.
    Deli MA
    Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracellular drug absorption enhancement through tight junction modulation.
    Lemmer HJ; Hamman JH
    Expert Opin Drug Deliv; 2013 Jan; 10(1):103-14. PubMed ID: 23163247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
    Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
    Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in absorption enhancers based on tight junction.
    Kondoh M; Yagi K
    Expert Opin Drug Deliv; 2007 May; 4(3):275-86. PubMed ID: 17489654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
    Sahni JK; Chopra S; Ahmad FJ; Khar RK
    J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in study of novel absorption enhancers based on tight junctions].
    Kang A; Liang Y; Hao HP; Xie L; Wang GJ
    Yao Xue Xue Bao; 2007 Nov; 42(11):1122-8. PubMed ID: 18300465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight junction modulation and its relationship to drug delivery.
    Salama NN; Eddington ND; Fasano A
    Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
    Richard J
    Ther Deliv; 2017 Jul; 8(8):663-684. PubMed ID: 28730934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
    Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
    Yamamoto A
    Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
    Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
    Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delivery system design for improvement of intestinal absorption of peptide drugs].
    Muranishi S
    Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiral progression in the development of absorption enhancers based on the biology of tight junctions.
    Kondoh M; Takahashi A; Yagi K
    Adv Drug Deliv Rev; 2012 May; 64(6):515-22. PubMed ID: 21802464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.